Table 2.
Fatty acids | F | M | P values | ||
---|---|---|---|---|---|
LIVER | Total C16 | 34.5 ± 0.8 | 32.9 ± 0.3 | ns | |
Total C18 | 63.6 ± 0.3 | 64.7 ± 0.6 | ns | ||
Total C20 | 1.2 ± 0.4 | 1.8 ± 0.3 | ns | ||
C18:0/C16:0 | 0.02 ± 0.01 | 0.09 ± 0.01 | ** | P < 0.01 | |
C18:1/C18:0 | 146 ± 46 | 25 ± 3 | * | P < 0.05 | |
C16:0/C18:2 | 10.2 ± 0.8 | 4.3 ± 0.6 | ** | P < 0.01 | |
Total SFA (%) | 27.2 ± 0.4 | 27.5 ± 0.5 | ns | ||
Total MUFA (%) | 69.3 ± 0.2 | 65.4 ± 1.2 | * | P < 0.05 | |
Total PUFA (%) | 3.0 ± 0.3 | 7.2 ± 0.8 | ** | P < 0.01 | |
MUFA/SFA | 2.5 ± 0.0 | 2.4 ± 0.1 | ns | ||
PUFA/SFA | 0.1 ± 0.0 | 0.3 ± 0.0 | ** | P < 0.01 | |
MUFA/PUFA | 22.4 ± 1.9 | 9.6 ± 1.3 | ** | P < 0.01 | |
gAT | Total C16 | 53.2 ± 3.6 | 43.8 ± 0.8 | * | P < 0.05 |
Total C18 | 45.9 ± 3.4 | 55.2 ± 0.9 | * | P < 0.05 | |
C16:1/C16:0 | 0.46 ± 0.03 | 0.35 ± 0.02 | * | P < 0.05 | |
Total SFA (%) | 37.1 ± 3.2 | 33.3 ± 0.4 | ns | ||
Total MUFA (%) | 45.5 ± 1.2 | 45.2 ± 1.5 | ns | ||
Total PUFA (%) | 18.8 ± 0.4 | 21.3 ± 1.6 | ns | ||
MUFA/SFA | 1.3 ± 0.1 | 1.4 ± 0.1 | ns | ||
PUFA/SFA | 0.6 ± 0.0 | 0.6 ± 0.1 | ns | ||
MUFA/PUFA | 2.5 ± 0.1 | 2.2 ± 0.2 | ns | ||
iAT | Total C16 | 42.2 ± 4.4 | 35.3 ± 2.4 | ns | |
Total C18 | 55.0 ± 3.7 | 66.0 ± 2.3 | * | P < 0.05 | |
C16:1/C16:0 | 0.49 ± 0.03 | 0.42 ± 0.08 | ns | ||
Total SFA (%) | 30.2 ± 3.4 | 26.0 ± 0.7 | ns | ||
Total MUFA (%) | 50.3 ± 2.2 | 48.0 ± 2.7 | ns | ||
Total PUFA (%) | 18.5 ± 0.8 | 28.5 ± 2.0 | * | P ≤ 0.01 | |
MUFA/SFA | 1.7 ± 0.2 | 1.8 ± 0.1 | ns | ||
PUFA/SFA | 0.6 ± 0.1 | 1.1 ± 0.1 | * | P < 0.05 | |
MUFA/PUFA | 2.7 ± 0.1 | 1.7 ± 0.2 | * | P ≤ 0.01 |
Data are presented as mean ± sem, n = 3–4. Differences between sexes were determined by two-tailed Student’s t test with statistical significance determined using the Holm-Sidak method, with alpha = 5.000%. Each row was analyzed individually, without assuming a consistent SD. *, P < 0.05, **, P < 0.01, M vs F were considered significant. ns = not significant. M male, F female, SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, gAT perigonadal adipose tissue and iAT inguinal adipose tissue